You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Melanocortin Receptor Sub-type 1 (MC1R)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Melanoma (Skin), Metastatic Melanoma, Melanoma Stage IV Trial in Iowa City, Rochester, Madison ([212Pb]VMT01)

Not yet recruiting
  • Melanoma (Skin)
  • +5 more
  • Iowa City, Iowa
  • +2 more
Dec 8, 2022

Melanoma (Skin), Melanoma Stage IV, Melanoma, Uveal Trial in Rochester ([203Pb]VMT01, [68Ga]VMT02)

Recruiting
  • Melanoma (Skin)
  • +3 more
  • Rochester, Minnesota
    Mayo Clinic
Aug 5, 2022

Patients With Obesity and Specific Gene Defects in the Melanocortin-4 Receptor Pathway Trial (Setmelanotide, Placebo)

Not yet recruiting
  • Patients With Obesity and Specific Gene Defects in the Melanocortin-4 Receptor Pathway
  • (no location specified)
Oct 13, 2021

Obesity Associated With Defects in Leptin-melanocortin Pathway Trial in Worldwide (Setmelanotide)

Enrolling by invitation
  • Obesity Associated With Defects in Leptin-melanocortin Pathway
  • Chandler, Arizona
  • +31 more
Dec 6, 2022

Bardet Biedl Syndrome (BBS), Alström Syndrome (AS) Trial in Worldwide (Setmelanotide, Placebos)

Completed
  • Bardet Biedl Syndrome (BBS)
  • Alström Syndrome (AS)
  • San Diego, California
  • +11 more
Jul 19, 2021

Type 1 Diabetes Trial in Montreal (device, drug, other)

Completed
  • Type 1 Diabetes
  • Single-hormone closed-loop system
  • +9 more
  • Montreal, Quebec, Canada
  • +1 more
Jan 13, 2022

Chronic Kidney Diseases Trial in Worldwide (Zibotentan, Dapagliflozin, Placebo)

Enrolling by invitation
  • Chronic Kidney Diseases
  • Aurora, Colorado
  • +5 more
Oct 18, 2022

Leptin Receptor Deficiency Obesity Trial in Worldwide (setmelanotide, Placebo)

Completed
  • Leptin Receptor Deficiency Obesity
  • New York, New York
  • +6 more
Jan 26, 2021

Diabetes, Diabetes, Type 2 Trial in Nijmegen (111In-DTPA-exendin-4, IRDye800CW-exendin-4)

Unknown status
  • Diabetes Mellitus
  • Diabetes Mellitus, Type 2
  • Nijmegen, Gelderland, Netherlands
    Radboud University Medical Center
Jan 28, 2021

Kidney Disease Trial in United States (Bremelanotide, RAAS inhibition therapy)

Recruiting
  • Kidney Disease
  • Chula Vista, California
  • +5 more
Jan 23, 2023

Genetic Obesity Trial in Spain, United Kingdom, United States (Setmelanotide, Placebo)

Recruiting
  • Genetic Obesity
  • Dearborn, Michigan
  • +13 more
Jun 14, 2022

Bardet-Biedl Syndrome, POMC Deficiency Trial in Marshfield (Setmelanotide 20mg weekly, Placebo daily, Setmelanotide 30mg weekly)

Enrolling by invitation
  • Bardet-Biedl Syndrome
  • POMC Deficiency
  • Setmelanotide 20mg weekly
  • +5 more
  • Marshfield, Wisconsin
    Marshfield Clinic Research Institute
Jan 25, 2022

Obesity, Child Trial (sequencing of a panel of 14 genes in leptin melanocortin pathway)

Not yet recruiting
  • Obesity, Child
  • sequencing of a panel of 14 genes in leptin melanocortin pathway
  • (no location specified)
Jul 3, 2023

Glucagon-like Peptide-1 Receptor Agonists According to Type 2

Recruiting
  • Diabetes Mellitus, Type 2
  • GLP-1 receptor agonist
  • Bari, Italy
    Azienda Ospedaliero-Universitaria Policlinico Bari
Nov 4, 2023

Lymphocytes of Polymyalgia Patients

Completed
  • Polymyalgia Rheumatica
  • Blood samples before and after standard of care of polymyalgia rheumatica
  • (no location specified)
Jan 11, 2023

Hypoactive Sexual Desire Disorder Trial in London (Bremelanotide, Placebo)

Recruiting
  • Hypoactive Sexual Desire Disorder
  • London, United Kingdom
    Imperial College Healthcare NHS Trust
Mar 9, 2022

Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Locally Advanced Breast Carcinoma Trial in

Not yet recruiting
  • Anatomic Stage III Breast Cancer AJCC v8
  • +14 more
  • Biopsy
  • +25 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Jul 12, 2022

Type2 Diabetes, Dyslipidemia Trial in Worldwide (K-877, Placebo)

Terminated
  • Type2 Diabetes
  • Dyslipidemia
  • Birmingham, Alabama
  • +887 more
Dec 20, 2022

Pro-opiomelanocortin (POMC) Deficiency Obesity (Heterozygous or Epigenetic), Leptin Receptor Deficiency Obesity, Smith-Magenis

Completed
  • Genetic Obesity
  • +2 more
  • Birmingham, Alabama
  • +57 more
Dec 22, 2022

Familial Chylomicronemia Syndrome Trial in Worldwide (Olezarsen, Placebo)

Active, not recruiting
  • Familial Chylomicronemia Syndrome
  • Huntington Beach, California
  • +47 more
Aug 6, 2022

Diabetes, Type 2 Trial in Amsterdam (device, drug, other)

Recruiting
  • Diabetes Mellitus, Type 2
  • ReCET
  • +2 more
  • Amsterdam, North-Holland, Netherlands
    Amsterdam UMC
Aug 9, 2023

Fat Metabolism and Melanocortin 3 Receptors in African Americans

Terminated
  • Obesity
  • Healthy Volunteers
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Jun 29, 2021

    Skin Cancer Trial in Salt Lake City (Education, Action Plan, UV Photo)

    Not yet recruiting
    • Skin Cancer
    • Education
    • +3 more
    • Salt Lake City, Utah
      Huntsman Cancer Institute
    Dec 1, 2022

    Clinical Phenotypes in Pericarditis: IL-1RA Antibodies and suPAR

    Not yet recruiting
    • Pericarditis
    • IL1RA Antibody Assay
    • suPAR Testing
    • Homburg, Germany
    • +8 more
    Jun 22, 2023

    Breast Cancer Trial in Fort Collins, Greeley, Loveland (vepdegestrant, Samuraciclib)

    Not yet recruiting
    • Breast Cancer
    • Fort Collins, Colorado
    • +3 more
    Nov 4, 2023